Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer’s disease model is a research paper published in The Journal of Experimental Medicine (2020). On theSindex it has a DataRank of 0.953. It has been cited 572 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.953
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: RF1AG05148501
National Institutes of Health
Grant: R21 AG059176
National Institutes of Health
Grant: RF1 AG059082
Cure Alzheimer’s Fund
FWCI
22.21
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Additional file 1 of The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Additional file 2 of The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Additional file 2 of The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Additional file 3 of The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Additional file 3 of The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Additional file 4 of The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Additional file 4 of The Alzheimer’s disease-associated protective Plcγ2-P522R variant promotes immune functions
Additional file 1 of Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model
Additional file 1 of Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model
Additional file 1 of Decrease in naturally occurring antibodies against epitopes of Alzheimer’s disease (AD) risk gene products is associated with cognitive decline in AD
Additional file 1 of Decrease in naturally occurring antibodies against epitopes of Alzheimer’s disease (AD) risk gene products is associated with cognitive decline in AD
Additional file 1 of Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice
Additional file 1 of Alzheimer’s disease associated isoforms of human CD33 distinctively modulate microglial cell responses in 5XFAD mice
Additional file 2 of Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
Additional file 6 of Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
Additional file 5 of Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
Additional file 2 of Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
Additional file 5 of Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology
Additional file 1 of Trem2 H157Y increases soluble TREM2 production and reduces amyloid pathology